HOME › DRUGS › DATOPOTAMAB DERUXTECAN-DLNK
ACTIVE SUBSTANCE / INN

DATOPOTAMAB DERUXTECAN-DLNK

Brand name(s): DATROWAY
FDA LISTED
PRESCRIPTION
BLA761464
ACTIVE SUBSTANCE
Datopotamab Deruxtecan-Dlnk
REGULATORS
FDA
SPONSORS / MAH
DAIICHI SANKYO INC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DATROWAYBLA761464DAIICHI SANKYO INCPrescription

FULL INTELLIGENCE ON DATOPOTAMAB DERUXTECAN-DLNK

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →